In a Geriatrics & Gerontology International study of 51 individuals living with dementia who attended community-based adult day health centers, behavioral observations of a music intervention showed a positive change in mood and a decrease in agitation.
Researchers at the University of Helsinki have discovered a mechanism by which harmful tau protein aggregates are transmitted between neurons. Alongside amyloid plaques, tau aggregates in the brain are a significant factor in the progression of Alzheimer's disease.
Doctors may one day be able to gauge a patient's risk of dementia with an MRI scan, according to a new study from Washington University School of Medicine in St. Louis. Using a new technique for analyzing MRI data, researchers were able to predict who would experience cognitive decline with 89 percent accuracy.
A DNA vaccine tested in mice reduces accumulation of both types of toxic proteins associated with Alzheimer's disease, according to research that scientists say may pave the way to a clinical trial.
Improving staff training in care homes and reducing reliance on harmful medications saves thousands of pounds per year, as well as improving quality of life and reducing agitation in dementia, new research has demonstrated.
Low-protein high-carbohydrate diets may be the key to longevity, and healthy brain ageing in particular, according to a new mice study from the University of Sydney.
MRI brain scans perform better than common clinical tests at predicting which people will go on to develop Alzheimer's disease, according to a new study.
One in five people with Alzheimer's disease (AD) who use a benzodiazepine are also concomitant users of an opioid, according to a new study from the University of Eastern Finland. Concomitant use was more common in comparison persons, but those with AD used strong opioids more frequently. About half of all concomitant users were prolonged users whose use of these drugs had continued for more than three consecutive months.
The researchers explored the efficacy of a multi-therapy approach based on the disease risk factor status specific to individuals with Alzheimer's disease (AD) diagnosis or concern. The findings indicate previously unidentified connectivity between AD risk factors, suggesting that treatment regimens should be tailored to the individual and multi-modal to simultaneously return several risk factors to a normative state.
Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New Salk research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.